Display Settings:

Format

Send to:

Choose Destination
    Cell Prolif. 2011 Apr;44 Suppl 1:60-9. doi: 10.1111/j.1365-2184.2010.00729.x.

    The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine.

    Source

    CTI-LYON, Cell Therapy Research Institute, Parc Technologique de Lyon St Priest, France.

    Abstract

    Science and medicine place a lot of hope in the development of stem cell research and regenerative medicine. This review will define the concept of regenerative medicine and focus on an abundant stem cell source - neonatal tissues such as the umbilical cord. Umbilical cord blood has been used clinically for over 20 years as a cell source for haematopoietic stem cell transplantation. Beyond this, cord blood and umbilical cord-derived stem cells have demonstrated potential for pluripotent lineage differentiation (liver, pancreatic, neural tissues and more) in vitro and in vivo. This promising research has opened up a new era for utilization of neonatal stem cells, now used beyond haematology in clinical trials for autoimmune disorders, cerebral palsy or type I diabetes.

    © 2011 Blackwell Publishing Ltd.

    PMID:
    21481046
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Blackwell Publishing

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk